Article

Whole Genome and Exome Sequencing Reference Datasets from A Multi-center and Cross-platform Benchmark Study

2021-02-27

Abstract excerpt

With the rapid advancement of sequencing technologies in the past decade, next generation sequencing (NGS) analysis has been widely applied in cancer genomics research. More recently, NGS has been adopted in clinical oncology to advance personalized medicine. Clinical applications of precision oncology require accurate tests that can distinguish tumor-specific mutations from errors or artifacts introduced during N...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a42d19f6-757c-5d68-a69a-40596def2b90
DOI: 10.1101/2021.02.27.433136

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Whole Genome and Exome Sequencing Reference Datasets from A Multi-center and Cross-platform Benchmark StudyDOI 10.1101/2021.02.27.433136Read

Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.Semantic proximity Read

Establishing reference samples for detection of somatic mutations and germline variants with NGS technologiesSemantic proximity Read

Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Semantic proximity Read

Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.Semantic proximity Read

A somatic reference standard for cancer genome sequencing.Semantic proximity Read

Validation and benchmarking of targeted panel sequencing for cancer genomic profiling.Semantic proximity Read

Achieving reproducibility and accuracy in cancer mutation detection with whole-genome and whole-exome sequencingSemantic proximity Read

Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity.Semantic proximity Read

A comprehensive multicenter comparison of whole genome sequencing pipelines using a uniform tumor-normal sample pairSemantic proximity Read

Benchmarking whole exome sequencing in the German network for personalized medicineSemantic proximity Read

Evaluating the analytical validity of mutation calling pipeline for tumor whole exome sequencingSemantic proximity Read

Evaluating discordant somatic calls across mutation discovery approaches to minimize false negative drug-resistant findingsSemantic proximity Read